These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4397793)

  • 1. The effect of some beta-adrenoceptive blocking drugs on glucose-6-phosphate and fructose-1,6-phosphate levels, and on hexokinase activity in the mouse brain.
    Leonard BE; Watkinson WD
    Life Sci II; 1971 Jun; 10(12):677-83. PubMed ID: 4397793
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of some beta-adrenergic blocking and other drugs on brain lactate levels following electroshock.
    Leonard BE
    Neuropharmacology; 1971 Jul; 10(4):517-20. PubMed ID: 5094312
    [No Abstract]   [Full Text] [Related]  

  • 3. [ adrenergic blocking agents and amphetamine or apomorphine induced stereotyped behavior in rats].
    Simon P; Chermat R; Fosset MT; Boissier JR
    Psychopharmacologia; 1972; 23(4):357-64. PubMed ID: 4402045
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pindolol. New beta blocking agent. Effect on cardiac chronotropism and ionotropism and comparison of its activity with propranolol].
    Aquaro G; Baduini G; Pavia M; Poletti T
    Minerva Cardioangiol; 1972 Jun; 20(6):324-9. PubMed ID: 4402731
    [No Abstract]   [Full Text] [Related]  

  • 5. A potent beta-adrenoreceptor blocking drug: 4-(2-hydroxy-3-isopropylaminopropoxy)indole.
    Moore GE; O'Donnell SR
    J Pharm Pharmacol; 1970 Mar; 22(3):180-8. PubMed ID: 4399485
    [No Abstract]   [Full Text] [Related]  

  • 6. Possible mechanism (s) of alprenolol (beta adrenergic receptor blocking agent) prolongation of pentobarbital hypnosis in mice.
    Peters MA
    J Pharmacol Exp Ther; 1972 Jun; 181(3):417-24. PubMed ID: 4402372
    [No Abstract]   [Full Text] [Related]  

  • 7. Increased plasma renin activity induced in rats by physostigmine and effects of alpha- and beta-receptors blocking drugs thereon.
    Alexandre JM; Menard J; Chevillard C; Schmitt H
    Eur J Pharmacol; 1970 Sep; 12(1):127-31. PubMed ID: 4394344
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of LB-46, a new beta adrenergic blocking agent, on pulse and blood pressure at rest and after exercise in healthy volunteers.
    Mehta AB; Cooverji ND; Agrawal AB; Shah AC; Patnekar PN; Vora DD
    J Assoc Physicians India; 1971 Nov; 19(11):765-70. PubMed ID: 4399862
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative studies with the beta-receptor blockaders LB 46 and propranolol in healthy persons using the isoproterenol test].
    Bender F; Dotterweich K
    Med Welt; 1971 Sep; 22(37):1444-6. PubMed ID: 4398359
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of pindolol on the metabolic activities of adrenaline].
    Schmitt H; Lucet B
    C R Seances Soc Biol Fil; 1970; 164(11):2193-5. PubMed ID: 4399994
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of beta-adrenergic blocking activity of DCI, H56-28, ICI50172, LB46, methoxamine, MJ1999 and propranolol in the blood perfused canine papillary muscle preparation.
    Hashimoto K; Endoh M; Tamura K; Taira N
    Experientia; 1970; 26(7):757-9. PubMed ID: 4393455
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of beta-adrenergic blocking compounds on tissue catecholamine levels.
    Klinge EA
    Eur J Pharmacol; 1971 Apr; 14(2):124-9. PubMed ID: 4151170
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of immediate haemodynamic effects of three beta-adrenergic blocking agents.
    Rivier JL; Nissiotis E; Jaeger M
    Postgrad Med J; 1970 Nov; ():Suppl:44-9. PubMed ID: 4395457
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of several beta-adrenergic inhibitors on auriculoventricular conduction].
    Boissier JR; Giudicelli JF; Mouillé P
    C R Seances Soc Biol Fil; 1970 Sep; 164(2):255-9. PubMed ID: 4394626
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiac catecholamine levels and blood pressure after chronic treatment with beta-adrenergic blocking agents.
    Mazurkiewicz-Kwilecki IM; Romagnoli A
    J Pharm Pharmacol; 1970 Mar; 22(3):235-7. PubMed ID: 4399498
    [No Abstract]   [Full Text] [Related]  

  • 16. The influence of propranolol, INPEA, iproveratril and some 1-naphthylethylamine derivatives on the myocardial phosphorylase activity.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1970 Apr; 19(4):1221-7. PubMed ID: 4398008
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of some -adrenergic blocking agents on the acetylcholine content of heart. An experimental study in mice.
    Khanna NK
    Eur J Pharmacol; 1972 Feb; 17(2):309-11. PubMed ID: 4402099
    [No Abstract]   [Full Text] [Related]  

  • 18. New beta-adrenergic blocking agents. Cyclopropylphenyl derivatives.
    Boissier JR; Ratouis R; Dumont C; Derible PH; Lavaux JP
    J Med Chem; 1970 Sep; 13(5):971-3. PubMed ID: 4394057
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of tests of adrenergic beta-receptor blockade in man and their application to a comparison of the beta-blocking potency of propranolol and oxprenolol.
    Taylor SH; Majid PA; Sharma B
    Postgrad Med J; 1970 Nov; ():Suppl:57-60. PubMed ID: 4395459
    [No Abstract]   [Full Text] [Related]  

  • 20. Action of some -blockers on plasma fibrinolysis in vitro and in vivo in man.
    Ponari O; Civardi E; Potì R
    Arzneimittelforschung; 1972 Mar; 22(3):629-31. PubMed ID: 4402605
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.